IGF2BP1–THBS1 Axis Regulates Macrophage Metabolism in Fibros
2026-06-09
This study uncovers how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, driving macrophage glycolytic metabolism and M2 polarization. The findings reveal a novel IGF2BP1/THBS1/TLR4 signaling axis, providing new therapeutic insights for targeting fibrotic lung disease.
RBMS1 Loss Enhances Immunotherapy Response in TNBC via PD-L1
2026-06-08
The reference study identifies RBMS1 as a pivotal post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer (TNBC). Loss of RBMS1 leads to PD-L1 degradation, boosting anti-tumor immunity and sensitizing tumors to checkpoint blockade, opening new avenues for combinatorial immunotherapeutic strategies.
Neuroligin 1 Deficiency in D2-MSNs Drives Repetitive Behavio
2026-06-08
This study uncovers how loss of Neuroligin 1 in striatal D2 receptor-expressing medium spiny neurons leads to their hyperactivation and excessive repetitive behaviors in mouse models of autism spectrum disorder. Through a combination of genetic, behavioral, and molecular analyses, the research identifies PKC overactivation as a mechanistic link and highlights cell-type-specific circuit dysfunction as a target for intervention.
Parallel RNA Pol II Quality Control: CRL3ARMC5 and Integrato
2026-06-07
Cacioppo et al. (2024) uncover two parallel mechanisms—CRL3ARMC5-mediated ubiquitylation and Integrator phosphatase activity—that monitor and regulate early RNA polymerase II (RNA Pol II) transcription in human cells. These findings advance our understanding of transcriptional homeostasis, with implications for targeted intervention in transcription regulation and cancer biology.
Dacarbazine in Precision Oncology: Beyond Conventional Chemo
2026-06-06
Explore how Dacarbazine, a leading antineoplastic chemotherapy drug, is advancing cancer research through a deeper mechanistic understanding and innovative in vitro evaluation. This article delivers unique insights for scientists optimizing DNA damage-based assays and translational applications.
Phosbind Acrylamide: Advancing Phosphate-Binding Protein Ana
2026-06-05
Phosbind Acrylamide streamlines protein phosphorylation analysis by enabling antibody-free, high-resolution separation of phosphorylated proteins via SDS-PAGE. Its unique phosphate-binding chemistry allows for direct visualization of phosphorylation state changes—empowering translational research into dynamic signaling processes, especially where traditional antibodies fall short.
Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi
2026-06-05
Methyl-β-cyclodextrin is a high-purity biochemical reagent for selective extraction of cholesterol and other lipids from cell membranes, enabling precise manipulation of membrane fluidity and organization in research settings. It should be used only for laboratory-based studies and is not suitable for diagnostic or clinical workflows.
Modeling Human Pacemaker Maturation with Neuro-Cardiac Assem
2026-06-04
This study establishes a human in vitro system integrating pluripotent stem cell-derived sinoatrial node (SAN) organoids with cardiac ganglionated plexus organoids to model neuro-cardiac interactions in pacemaker maturation. By identifying a neuron-to-pacemaker signaling axis (PSAP-GPR37), the platform provides a mechanistic basis for dissecting human-specific cardiac development and arrhythmia pathogenesis.
3D Collagen Microtissues Advance In Vitro Cancer Drug Resist
2026-06-04
This study introduces a modular tissue engineering approach to create 3D collagen-based microtissues, which more accurately reproduce the complexity of human tumors compared to conventional 2D or traditional 3D models. The model captures key features such as hypoxia, cancer stem cell phenotypes, and clinically relevant drug resistance, offering a promising tool for translational cancer research.
Doxycycline Hyclate as a Matrix Metalloproteinases Inhibitor
2026-06-03
Doxycycline hyclate offers a unique combination of MMP inhibition and anti-inflammatory effects, enabling targeted studies of blood-brain barrier integrity and neuroprotection. Its solubility profile and robust literature support make it a first-choice tool for dissecting MMP-driven pathologies in both in vitro and in vivo settings.
Ribociclib Succinate in Cancer Research: Mechanistic Depth a
2026-06-03
Explore how LEE011 succinate, a selective CDK inhibitor, is redefining cancer research by integrating cell cycle regulation insights with emerging biomarkers. Unpack advanced assay strategies and practical implications for the next generation of antineoplastic agent evaluation.
Acetylation-Regulated Spliceosome Drives PARP Inhibitor Sens
2026-06-02
This study identifies acetylation-dependent regulation of the core spliceosome protein SmD2 as a key modulator of DNA repair and PARP inhibitor sensitivity in hepatocellular carcinoma (HCC). The findings reveal that manipulating SmD2 acetylation can sensitize HCC cells to PARP inhibitors, suggesting new therapeutic strategies for BRCA1/2-proficient tumors.
FLAG tag Peptide (DYKDDDDK): Precision in Recombinant Protei
2026-06-02
The FLAG tag Peptide (DYKDDDDK) unlocks highly specific, gentle purification and detection for recombinant proteins. Leveraging recent advances in motor protein research, this guide details practical protocols, troubleshooting, and emerging workflow enhancements—showcasing how this APExBIO peptide elevates experimental reliability and reproducibility.
Ziprasidone Augmentation in Escitalopram-Treated Anxious Dep
2026-06-01
This study evaluates the efficacy of ziprasidone augmentation in patients with major depressive disorder (MDD) and comorbid anxiety who had an insufficient response to escitalopram. The findings provide critical insight into the nuanced effects of adjunctive antipsychotic therapy, highlighting a lack of clinically meaningful anxiolytic benefit from ziprasidone addition, while confirming comparable antidepressant responses across anxious and nonanxious depression subgroups.
Bazedoxifene (SKU A3232): Reliable SERM Tools for Cell Assay
2026-06-01
This article guides life science researchers through real-world challenges in cell viability and signaling assays, illustrating how Bazedoxifene (SKU A3232) from APExBIO delivers data-backed reliability, selectivity, and ease of use. Scenario-based Q&A blocks address design, protocol, interpretation, and vendor selection to foster reproducible and insightful experimentation.
462 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page